Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
29
AVAV Quote, Financials, Valuation and Earnings
Last price:
$164.01
Seasonality move
:
3.13%
Day range:
$158.18 - $165.62
52-week range:
$116.51 - $236.60
Dividend yield:
0%
P/E ratio:
94.33x
P/S ratio:
6.07x
P/B ratio:
5.39x
Volume:
1.3M
Avg. volume:
646.9K
1-year change:
29.83%
Market cap:
$4.6B
Revenue:
$716.7M
EPS (TTM):
$1.74
| Period Ending | 2020-04-30 | 2021-04-30 | 2022-04-30 | 2023-04-30 | 2024-04-30 | |
|---|---|---|---|---|---|---|
| Revenue | $367.3M | $394.9M | $445.7M | $540.5M | $716.7M | |
| Revenue Growth (YoY) | 16.87% | 7.52% | 12.87% | 21.27% | 32.59% | |
| Cost of Revenues | $214.2M | $230.4M | $304.5M | $367M | $432.8M | |
| Gross Profit | $153.1M | $164.6M | $141.2M | $173.5M | $283.9M | |
| Gross Profit Margin | 41.68% | 41.67% | 31.69% | 32.1% | 39.62% | |
| R&D Expenses | $46.5M | $53.8M | $54.7M | $64.3M | $97.7M | |
| Selling, General & Admin | $59.5M | $67.5M | $96.4M | $131.9M | $114.4M | |
| Other Inc / (Exp) | $707K | -$8.3M | -$3.8M | -$156.4M | -$4.4M | |
| Operating Expenses | $106M | $121.2M | $151.1M | $196.2M | $212.1M | |
| Operating Income | $47.1M | $43.3M | -$9.9M | -$22.6M | $71.8M | |
| Net Interest Expenses | -- | $618K | $5.4M | $9.4M | $4.2M | |
| EBT. Incl. Unusual Items | $52.7M | $34.4M | -$19.1M | -$188.4M | $63.2M | |
| Earnings of Discontinued Ops. | -$265K | -- | -- | -- | -- | |
| Income Tax Expense | $5.8M | $539K | -$10.4M | -$14.7M | $1.9M | |
| Net Income to Company | $41.3M | $23.3M | -$4.2M | -$176.2M | $59.7M | |
| Minority Interest in Earnings | $4K | -$14K | -$3K | -$45K | -- | |
| Net Income to Common Excl Extra Items | $41.1M | $23.3M | -$4.2M | -$176.2M | $59.7M | |
| Basic EPS (Cont. Ops) | $1.73 | $0.97 | -$0.17 | -$7.04 | $2.19 | |
| Diluted EPS (Cont. Ops) | $1.71 | $0.96 | -$0.17 | -$7.04 | $2.18 | |
| Weighted Average Basic Share | $23.8M | $24M | $24.7M | $25M | $27.2M | |
| Weighted Average Diluted Share | $24.1M | $24.4M | $24.7M | $25M | $27.3M | |
| EBITDA | $57M | $54.2M | $47.1M | -$79M | $103.2M | |
| EBIT | $47.1M | $35M | -$13.7M | -$179M | $67.5M | |
| Revenue (Reported) | $367.3M | $394.9M | $445.7M | $540.5M | $716.7M | |
| Operating Income (Reported) | $47.1M | $43.3M | -$9.9M | -$22.6M | $71.8M | |
| Operating Income (Adjusted) | $47.1M | $35M | -$13.7M | -$179M | $67.5M | |
| Period Ending | 2020-10-31 | 2021-10-31 | 2022-10-31 | 2023-10-31 | 2024-10-31 | |
|---|---|---|---|---|---|---|
| Revenue | $92.7M | $122M | $111.6M | $180.8M | $188.5M | |
| Revenue Growth (YoY) | 11.28% | 31.67% | -8.54% | 62.05% | 4.23% | |
| Cost of Revenues | $51.8M | $79.6M | $85.7M | $105.5M | $114.8M | |
| Gross Profit | $40.9M | $42.5M | $25.9M | $75.4M | $73.6M | |
| Gross Profit Margin | 44.09% | 34.8% | 23.2% | 41.67% | 39.07% | |
| R&D Expenses | $12M | $14.3M | $16.6M | $22M | $28.7M | |
| Selling, General & Admin | $15M | $24.8M | $23.6M | $28.1M | $37.9M | |
| Other Inc / (Exp) | $72K | -$10M | $810K | -$2.9M | $16K | |
| Operating Expenses | $27M | $39.1M | $40.2M | $50.2M | $66.6M | |
| Operating Income | $13.9M | $3.3M | -$14.3M | $25.2M | $7M | |
| Net Interest Expenses | -- | $1.4M | $2.3M | $2M | $690K | |
| EBT. Incl. Unusual Items | $14.1M | -$8.1M | -$15.8M | $20.4M | $6.3M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $2.5M | -$9.5M | -$10.5M | $1.1M | -$221K | |
| Net Income to Company | $2.1M | $2.6M | -$6.6M | $17.8M | $7.5M | |
| Minority Interest in Earnings | $22K | -$31K | -$39K | -- | -- | |
| Net Income to Common Excl Extra Items | $2.1M | $2.5M | -$6.7M | $17.8M | $7.5M | |
| Basic EPS (Cont. Ops) | $0.09 | $0.10 | -$0.27 | $0.66 | $0.27 | |
| Diluted EPS (Cont. Ops) | $0.09 | $0.10 | -$0.27 | $0.66 | $0.27 | |
| Weighted Average Basic Share | $23.9M | $24.6M | $24.9M | $26.9M | $28M | |
| Weighted Average Diluted Share | $24.2M | $24.9M | $24.9M | $27M | $28.1M | |
| EBITDA | $16.8M | $9.7M | $4.8M | $30.8M | $16M | |
| EBIT | $13.9M | -$6.7M | -$13.5M | $22.3M | $7M | |
| Revenue (Reported) | $92.7M | $122M | $111.6M | $180.8M | $188.5M | |
| Operating Income (Reported) | $13.9M | $3.3M | -$14.3M | $25.2M | $7M | |
| Operating Income (Adjusted) | $13.9M | -$6.7M | -$13.5M | $22.3M | $7M | |
| Period Ending | 2020-10-31 | 2021-10-31 | 2022-10-31 | 2023-10-31 | 2024-10-31 | |
|---|---|---|---|---|---|---|
| Revenue | $377.2M | $437.8M | $442.8M | $653.6M | $761.5M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $224.3M | $278.3M | $313.2M | $398.7M | $463.5M | |
| Gross Profit | $152.9M | $159.5M | $129.7M | $254.9M | $298M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $50M | $58.7M | $58.3M | $70.1M | $113.5M | |
| Selling, General & Admin | $56.6M | $92.4M | $90M | $138.3M | $134.2M | |
| Other Inc / (Exp) | $300K | -$18.8M | $7M | -$160.8M | -$604K | |
| Operating Expenses | $106.5M | $151.1M | $148.4M | $208.4M | $247.7M | |
| Operating Income | $46.4M | $8.3M | -$18.7M | $46.5M | $50.3M | |
| Net Interest Expenses | -- | $3.6M | $6.7M | $9.4M | $1.2M | |
| EBT. Incl. Unusual Items | $49.2M | -$14.1M | -$18.4M | -$123.7M | $48.5M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $6.3M | -$13.6M | -$7.8M | -$4.4M | $704K | |
| Net Income to Company | $28.8M | -$132K | -$7.8M | -$121.4M | $48.6M | |
| Minority Interest in Earnings | $56K | -$167K | $46K | -- | -- | |
| Net Income to Common Excl Extra Items | $28.6M | -$299K | -$7.8M | -$121.4M | $48.6M | |
| Basic EPS (Cont. Ops) | $1.20 | -$0.01 | -$0.32 | -$4.84 | $1.75 | |
| Diluted EPS (Cont. Ops) | $1.19 | -$0.02 | -$0.32 | -$4.84 | $1.74 | |
| Weighted Average Basic Share | -- | -- | -- | -- | -- | |
| Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
| EBITDA | $57.5M | $33.2M | $51.4M | -$31.2M | $88M | |
| EBIT | $46.4M | -$10.4M | -$11.7M | -$114.3M | $49.7M | |
| Revenue (Reported) | $377.2M | $437.8M | $442.8M | $653.6M | $761.5M | |
| Operating Income (Reported) | $46.4M | $8.3M | -$18.7M | $46.5M | $50.3M | |
| Operating Income (Adjusted) | $46.4M | -$10.4M | -$11.7M | -$114.3M | $49.7M | |
| Period Ending | 2020-10-31 | 2021-10-31 | 2022-10-31 | 2023-10-31 | 2024-10-31 | |
|---|---|---|---|---|---|---|
| Revenue | $180.1M | $223M | $220.1M | $333.2M | $377.9M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $103.9M | $151.8M | $160.5M | $192.2M | $222.8M | |
| Gross Profit | $76.3M | $71.2M | $59.6M | $141M | $155.1M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $23.1M | $28M | $31.6M | $37.5M | $53.3M | |
| Selling, General & Admin | $27M | $51.9M | $45.6M | $52M | $71.7M | |
| Other Inc / (Exp) | $105K | -$10.4M | $404K | -$4M | -$218K | |
| Operating Expenses | $50.1M | $80M | $77.2M | $89.5M | $125M | |
| Operating Income | $26.2M | -$8.8M | -$17.6M | $51.5M | $30.1M | |
| Net Interest Expenses | -- | $2.7M | $3.9M | $4M | $929K | |
| EBT. Incl. Unusual Items | $26.6M | -$21.8M | -$21.1M | $43.6M | $28.9M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $3.7M | -$10.5M | -$7.9M | $2.5M | $1.3M | |
| Net Income to Company | $12.1M | -$11.4M | -$15M | $39.7M | $28.7M | |
| Minority Interest in Earnings | $59K | -$94K | -$45K | -- | -- | |
| Net Income to Common Excl Extra Items | $12.2M | -$11.5M | -$15.1M | $39.7M | $28.7M | |
| Basic EPS (Cont. Ops) | $0.51 | -$0.47 | -$0.61 | $1.50 | $1.03 | |
| Diluted EPS (Cont. Ops) | $0.51 | -$0.47 | -$0.61 | $1.50 | $1.02 | |
| Weighted Average Basic Share | $47.8M | $49.3M | $49.7M | $53M | $56M | |
| Weighted Average Diluted Share | $48.4M | $49.5M | $49.7M | $53.1M | $56.4M | |
| EBITDA | $31.9M | $10.9M | $15.1M | $62.9M | $47.7M | |
| EBIT | $26.2M | -$19.2M | -$17.2M | $47.6M | $29.8M | |
| Revenue (Reported) | $180.1M | $223M | $220.1M | $333.2M | $377.9M | |
| Operating Income (Reported) | $26.2M | -$8.8M | -$17.6M | $51.5M | $30.1M | |
| Operating Income (Adjusted) | $26.2M | -$19.2M | -$17.2M | $47.6M | $29.8M | |
| Period Ending | 2020-04-30 | 2021-04-30 | 2022-04-30 | 2023-04-30 | 2024-04-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $255.1M | $148.7M | $77.2M | $132.9M | $73.3M | |
| Short Term Investments | $47.5M | $32M | $24.7M | -- | -- | |
| Accounts Receivable, Net | $73.7M | $62.6M | $60.2M | $87.6M | $70.3M | |
| Inventory | $45.5M | $71.6M | $90.6M | $138.8M | $150.2M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $6.2M | $15M | $11.5M | $12M | $22.3M | |
| Total Current Assets | $503.9M | $401.6M | $368.9M | $477M | $515.6M | |
| Property Plant And Equipment | $30.5M | $81.8M | $89.1M | $67.2M | $76.6M | |
| Long-Term Investments | $15M | $12.2M | $15.4M | $23.6M | $21M | |
| Goodwill | $6.3M | $314.2M | $334.3M | $180.8M | $275.7M | |
| Other Intangibles | $13.6M | $106.3M | $97.2M | $43.6M | $72.2M | |
| Other Long-Term Assets | $10.6M | $10.4M | $1.9M | $5.2M | $13.5M | |
| Total Assets | $585M | $928.6M | $914.2M | $824.6M | $1B | |
| Accounts Payable | $19.9M | $24.8M | $19.2M | $31.4M | $48.3M | |
| Accrued Expenses | $24M | $28.1M | $25.4M | $35.6M | $44.3M | |
| Current Portion Of Long-Term Debt | -- | $10M | $10M | $7.5M | $10M | |
| Current Portion Of Capital Lease Obligations | $3.4M | $6.2M | $6.8M | $8.2M | $9.8M | |
| Other Current Liabilities | $10.8M | $19.1M | $30.2M | $19.6M | $17.1M | |
| Total Current Liabilities | $67M | $96.2M | $101.4M | $121.3M | $144.9M | |
| Long-Term Debt | -- | $187.5M | $177.8M | $125.9M | $17.1M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $75.1M | $316.5M | $306M | $273.6M | $193.1M | |
| Common Stock | $2K | $2K | $2K | $4K | $4K | |
| Other Common Equity Adj | $328K | $343K | -$6.5M | -$4.5M | -$5.6M | |
| Common Equity | $509.9M | $612.1M | $608M | $551M | $822.7M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | $14K | $241K | -- | -- | |
| Total Equity | $509.9M | $612.1M | $608.2M | $551M | $822.7M | |
| Total Liabilities and Equity | $585M | $928.6M | $914.2M | $824.6M | $1B | |
| Cash and Short Terms | $302.6M | $180.7M | $101.9M | $132.9M | $73.3M | |
| Total Debt | -- | $197.5M | $187.8M | $133.4M | $27.1M | |
| Period Ending | 2020-10-31 | 2021-10-31 | 2022-10-31 | 2023-10-31 | 2024-10-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $280.1M | $104.8M | $101.4M | $100.9M | $69M | |
| Short Term Investments | $67.1M | $6.3M | -- | -- | -- | |
| Accounts Receivable, Net | $30.7M | $26.6M | $31.7M | $73.9M | $73.9M | |
| Inventory | $51.8M | $81.9M | $109.8M | $181.8M | $139.7M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $7.3M | $13.8M | $13.2M | $20M | $18.4M | |
| Total Current Assets | $507.6M | $364.1M | $357.5M | $524M | $514.8M | |
| Property Plant And Equipment | $35.2M | $94.3M | $78M | $74.4M | $82.2M | |
| Long-Term Investments | $21M | $11.3M | $22.5M | $20.6M | $22.9M | |
| Goodwill | $6.3M | $335.9M | $335M | $274.8M | $275.8M | |
| Other Intangibles | $12.2M | $110.6M | $88.7M | $82.8M | $62.7M | |
| Other Long-Term Assets | $102K | $6.3M | $2M | $9.2M | $19.3M | |
| Total Assets | $588M | $925.3M | $891.7M | $1B | $1B | |
| Accounts Payable | $14.2M | $21.4M | $26.3M | $28.8M | $40.6M | |
| Accrued Expenses | $18.7M | $21.7M | $25M | $26.7M | $31.6M | |
| Current Portion Of Long-Term Debt | -- | $10M | $10M | $5M | -- | |
| Current Portion Of Capital Lease Obligations | $4M | $6.4M | $7.6M | $8.8M | $9.6M | |
| Other Current Liabilities | $10.5M | $31.3M | $27.8M | $18.9M | $19.1M | |
| Total Current Liabilities | $53.5M | $101.4M | $103.9M | $109.3M | $111.6M | |
| Long-Term Debt | -- | $182.8M | $155.6M | $73.7M | $15M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $64.2M | $325.1M | $284.2M | $213M | $160.7M | |
| Common Stock | $2K | $2K | $4K | $4K | $4K | |
| Other Common Equity Adj | $342K | -$1.7M | -$8.5M | -$6.1M | -$5.2M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -$59K | $332K | -- | -- | -- | |
| Total Equity | $523.8M | $600.2M | $607.5M | $793.7M | $858.4M | |
| Total Liabilities and Equity | $588M | $925.3M | $891.7M | $1B | $1B | |
| Cash and Short Terms | $347.2M | $111.1M | $101.4M | $100.9M | $69M | |
| Total Debt | -- | $192.8M | $165.6M | $78.7M | $15M | |
| Period Ending | 2020-04-30 | 2021-04-30 | 2022-04-30 | 2023-04-30 | 2024-04-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $41.3M | $23.3M | -$4.2M | -$176.2M | $59.7M | |
| Depreciation & Amoritzation | $9.9M | $19.3M | $60.8M | $100M | $35.7M | |
| Stock-Based Compensation | $6.2M | $6.9M | $5.4M | $10.8M | $17.1M | |
| Change in Accounts Receivable | -$64.8M | $25.6M | -$29.2M | -$28.4M | -$73.6M | |
| Change in Inventories | $8.9M | -$6.4M | -$29.4M | -$61.8M | -$23M | |
| Cash From Operations | $25.1M | $86.5M | -$9.6M | $11.4M | $15.3M | |
| Capital Expenditures | $11.2M | $11.3M | $22.3M | $14.9M | $24.5M | |
| Cash Acquisitions | -$33.1M | -$388.3M | -$46.5M | -$11.5M | -$27.2M | |
| Cash From Investing | $59.2M | -$378.8M | -$52.3M | -$7M | -$51.7M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | $200M | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -$10M | -$55M | -$107M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$1.9M | -$7.4M | -$9.4M | -$1.1M | -$4.3M | |
| Cash From Financing | -$1.8M | $194.2M | -$16.6M | $50.8M | -$22.9M | |
| Beginning Cash (CF) | $172.7M | $255.1M | $157.1M | $77.2M | $132.9M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $82.4M | -$98.1M | -$78.5M | $55.2M | -$59.3M | |
| Ending Cash (CF) | $255.1M | $157.1M | $77.2M | $132.9M | $73.3M | |
| Levered Free Cash Flow | $13.9M | $75.3M | -$31.9M | -$3.5M | -$9.2M | |
| Period Ending | 2020-10-31 | 2021-10-31 | 2022-10-31 | 2023-10-31 | 2024-10-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $2.1M | $2.6M | -$6.6M | $17.8M | $7.5M | |
| Depreciation & Amoritzation | $2.9M | $16.4M | $18.3M | $8.4M | $9M | |
| Stock-Based Compensation | $1.9M | $420K | $2.2M | $5M | $5.6M | |
| Change in Accounts Receivable | $15.9M | -$23.1M | $7.9M | -$32M | -$32.2M | |
| Change in Inventories | -$6.2M | -$4M | -$14.8M | -$9.3M | $3.6M | |
| Cash From Operations | $31.8M | $12M | $16M | -$8.5M | -$3.6M | |
| Capital Expenditures | $2M | $7.7M | $2.2M | $8M | $5M | |
| Cash Acquisitions | -- | -$3.6M | -$5.7M | -$26M | -- | |
| Cash From Investing | $1.5M | $1.6M | -$369K | -$34M | -$5M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | $15M | |
| Long-Term Debt Repaid | -- | -$2.5M | -$20M | -$50M | -$17.5M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$22K | -$8K | -$36K | -$578K | -$1M | |
| Cash From Financing | -$22K | -$2.5M | -$7.6M | $37.9M | -$3.5M | |
| Beginning Cash (CF) | $246.8M | $95.7M | $93.2M | $105.9M | $81.2M | |
| Foreign Exchange Rate Adjustment | -- | -$164K | $134K | -$291K | -$26K | |
| Additions / Reductions | $33.3M | $11M | $8.1M | -$4.7M | -$12.2M | |
| Ending Cash (CF) | $280.1M | $106.6M | $101.4M | $100.9M | $69M | |
| Levered Free Cash Flow | $29.8M | $4.2M | $13.9M | -$16.5M | -$8.7M | |
| Period Ending | 2020-10-31 | 2021-10-31 | 2022-10-31 | 2023-10-31 | 2024-10-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $28.8M | -$132K | -$7.8M | -$121.4M | $48.6M | |
| Depreciation & Amoritzation | $11.1M | $43.6M | $63.1M | $83.1M | $38.2M | |
| Stock-Based Compensation | $6.8M | $5.8M | $7.5M | $14.6M | $19M | |
| Change in Accounts Receivable | $1.5M | -$43M | $22.1M | -$85M | -$66.1M | |
| Change in Inventories | $990K | -$10.2M | -$46.1M | -$84.5M | $33.8M | |
| Cash From Operations | $75.8M | $24.6M | $25.7M | -$46.1M | $65.6M | |
| Capital Expenditures | $10.4M | $18.4M | $16.7M | $18.9M | $23.3M | |
| Cash Acquisitions | -$11.1M | -$439.5M | -$2.7M | -$29M | -$2.4M | |
| Cash From Investing | $71.5M | -$381.6M | -$14.1M | -$48.1M | -$25.7M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -$5M | -$27.5M | -$87.5M | -$80M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$3M | -$12.8M | -$3.1M | -$2.1M | -$7.4M | |
| Cash From Financing | -$2.9M | $183.8M | -$15.5M | $93.3M | -$71.9M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $144.4M | -$173.2M | -$3.9M | -$893K | -$32M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $65.3M | $6.2M | $8.9M | -$65M | $42.3M | |
| Period Ending | 2020-10-31 | 2021-10-31 | 2022-10-31 | 2023-10-31 | 2024-10-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $12.1M | -$11.4M | -$15M | $39.7M | $28.7M | |
| Depreciation & Amoritzation | $5.7M | $30M | $32.3M | $15.4M | $17.9M | |
| Stock-Based Compensation | $3.5M | $2.3M | $4.4M | $8.2M | $10.1M | |
| Change in Accounts Receivable | $48.4M | -$20.2M | $31.2M | -$25.4M | -$17.8M | |
| Change in Inventories | -$6.2M | -$10.1M | -$26.7M | -$49.3M | $7.5M | |
| Cash From Operations | $58.6M | -$3.3M | $31.9M | -$25.6M | $24.7M | |
| Capital Expenditures | $6.1M | $13.1M | $7.6M | $11.6M | $10.4M | |
| Cash Acquisitions | -$1.2M | -$52.4M | -$8.5M | -$26M | -$1.2M | |
| Cash From Investing | -$31.9M | -$34.8M | $3.4M | -$37.6M | -$11.6M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | $15M | |
| Long-Term Debt Repaid | -- | -$5M | -$22.5M | -$55M | -$28M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$1.8M | -$7.2M | -$867K | -$1.9M | -$5M | |
| Cash From Financing | -$1.7M | -$12.1M | -$10.9M | $31.5M | -$17.5M | |
| Beginning Cash (CF) | $502M | $252.8M | $170.4M | $238.7M | $154.5M | |
| Foreign Exchange Rate Adjustment | -- | -$275K | -$257K | -$270K | $51K | |
| Additions / Reductions | $25M | -$50.2M | $24.4M | -$31.7M | -$4.4M | |
| Ending Cash (CF) | $526.9M | $202.3M | $194.6M | $206.8M | $150.1M | |
| Levered Free Cash Flow | $52.5M | -$16.5M | $24.3M | -$37.2M | $14.3M | |
Get AVAV Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
AVAV
Sector
P/E ratio
94.33x
17.94x
PEG ratio
-0.03x
0.34x
P/B ratio
5.39x
1.76x
Price / LTM sales
6.07x
0.97x
Growth Metrics
AVAV
Sector
Revenue growth
4.23%
1.77%
Earnings growth
-59.09%
1.67%
Revenue (5-year growth)
17.93%
4.31%
Earnings forecast
$0.68
$0.46
Profitability
AVAV
Sector
Profitability FY 2024
$283.9M
$434.2M
Return on invested capital
5.64%
5.93%
Return on assets
4.84%
3.69%
Return on equity
5.88%
8.87%
Earnings Date
Last Earnings Date
Dec
4
Next Earnings Date
Mar
4
Estimated Next Earnings Date
Mar
5
Balance Sheet
AVAV
Sector
Total cash
$69M
$170.4M
Short term investments
--
$46.5M
Total assets
$1B
$2.1B
Long term debt
$15M
$147.8M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
